Stock MOJO MOJAVE BRANDS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Mojave Brands Inc.

Equities

MOJO

CA6083842022

Pharmaceuticals

Delayed Canadian Securities Exchange
Other stock markets
 18:08:40 16/05/2024 BST 		5-day change 1st Jan Change
0.255 CAD 0.00% Intraday chart for Mojave Brands Inc. -20.31% -49.00%
04-19 Mojave Brands Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024 CI
02-05 Mojave Brands Inc. announced that it expects to receive CAD 7.5 million in funding CI

Valuation

Fiscal Period: August 2018 2019 2020 2021 2022 2023
Capitalization 1 55.06 20.34 1.168 2.612 1.536 0.5633
Enterprise Value (EV) 1 40.02 18.73 1.151 1.746 0.6952 -0.1268
P/E ratio -3.21 x -0.45 x -0.18 x -7.15 x 22.9 x -8.18 x
Yield - - - - - -
Capitalization / Revenue 1,054 x 99.2 x - - - -
EV / Revenue 766 x 91.3 x - - - -
EV / EBITDA -4.64 x -1.93 x -0.47 x -23.6 x - -
EV / FCF -11.6 x -2.46 x -5.31 x 5.57 x -9.27 x 0.62 x
FCF Yield -8.61% -40.7% -18.8% 17.9% -10.8% 162%
Price to Book 1.46 x 4.07 x 6.96 x 4.1 x 2.18 x 0.89 x
Nbr of stocks (in thousands) 949 1,070 1,168 2,561 2,561 2,561
Reference price 2 58.00 19.00 1.000 1.020 0.6000 0.2200
Announcement Date 28/12/18 30/12/19 22/12/20 17/12/21 23/12/22 21/12/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: August 2018 2019 2020 2021 2022 2023
Net sales 1 0.0522 0.2051 - - - -
EBITDA 1 -8.627 -9.714 -2.461 -0.0739 - -
EBIT 1 -8.887 -10.92 -2.493 -0.106 0.0275 -0.197
Operating Margin -17,021.73% -5,326.3% - - - -
Earnings before Tax (EBT) 1 -9.178 -24.45 -3.056 -0.1182 0.0344 -0.0689
Net income 1 -9.164 -39.53 -6.529 -0.1886 0.0671 -0.0689
Net margin -17,551.12% -19,275.12% - - - -
EPS 2 -18.07 -41.87 -5.498 -0.1427 0.0262 -0.0269
Free Cash Flow 1 -3.445 -7.621 -0.2166 0.3133 -0.075 -0.2052
FCF margin -6,598.69% -3,716.46% - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 28/12/18 30/12/19 22/12/20 17/12/21 23/12/22 21/12/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: August 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 15 1.61 0.02 0.87 0.84 0.69
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -3.45 -7.62 -0.22 0.31 -0.08 -0.21
ROE (net income / shareholders' equity) -40% -105% -118% -29.4% 5.12% -10.3%
ROA (Net income/ Total Assets) -21.5% -28.3% -43.2% -8.25% 1.88% -15.6%
Assets 1 42.66 139.7 15.11 2.287 3.568 0.4408
Book Value Per Share 2 39.70 4.670 0.1400 0.2500 0.2700 0.2500
Cash Flow per Share 2 15.90 1.510 0.0500 0.3600 0.3400 0.2700
Capex 1 0.19 1.04 - - - -
Capex / Sales 358.02% 506.37% - - - -
Announcement Date 28/12/18 30/12/19 22/12/20 17/12/21 23/12/22 21/12/23
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
MOJAVE BRANDS INC. Stock Mojave Brands Inc.
-49.00% 1.75M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.06% 694B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 593B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.58% 371B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.84% 331B
ABBVIE INC. Stock AbbVie Inc.
+6.90% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 209B
NOVARTIS AG Stock Novartis AG
+10.02% 209B
AMGEN INC. Stock Amgen Inc.
+8.11% 169B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. MOJO Stock
  4. Financials Mojave Brands Inc.